glp-1 no bmi requirement and Weight Loss Treatment: What BMI Qualifies? GLP-1 Agonist: The Good, the

PLoS ONE 8:e66830

the same patient at 1.0 g/kg sits at 82 g/day

Am J Physiol Heart Circ Physiol 296:H1217H1220 Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA, Kass DA (2001) Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling

Patient has obesity with documented hypertension and prior sustained diet and exercise efforts without adequate response is much stronger because it describes medical necessity

This stage is marked by the onset of clinical symptoms associated with hyperglycemia, such as polyuria, polydipsia, weight loss, and fatigue